Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

Marine Maurel, Esther Kissling, Mariëtte Hooiveld(Netherlands Institute for Health Services Research), Mihaela Lazăr, Lisa Domegan(Health Service Executive), Marlena Kaczmarek(European Centre for Disease Prevention and Control), Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Gergő Túri(Semmelweis University), Ana Paula Rodrigues(Microsoft (Brazil)), Frederika Dijkstra(National Institute for Public Health and the Environment), Adam Meijer(National Centre for Infectious Diseases), Sanja Filipović(Hrvatski zavod za javno zdravstvo), Beatrix Oroszi, Ralf Dürrwald(IDT Biologika (Germany)), Amparo Larrauri(Instituto de Salud Carlos III), J Horváth(Semmelweis University), Olivia Carmen Timnea, Luise Goerlitz(Robert Koch Institute), Sabrina Bacci(European Centre for Disease Prevention and Control), Ana Ordax Diez(Instituto de Estudios de Ciencias de la Salud de Castilla y León), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Clara Mazagatos(Instituto de Salud Carlos III), Joan O’Donnell(Health Service Executive), Noémie Sève(Inserm), Iván Martínez‐Baz(Instituto de Salud Carlos III), Maja Ilić(Hrvatski zavod za javno zdravstvo), Rodica Popescu(National Institute of Public Health), Ivan Mlinarić(Hrvatski zavod za javno zdravstvo), Adele McKenna(Health Protection Surveillance Centre), Silke Buda(Robert Koch Institute)
Cited by 7


Related Papers